Search results
Results from the WOW.Com Content Network
Code Short-name Full name Listing date Issued capital Negotiable capital Industry Http English Chinese 000100: TCL: TCL集团: TCL Corporation: 30.01.2004: 13,549,648,507
This fund is benchmarked to the MSCI Emerging Markets ex China index, which tracks large- and mid-cap companies in emerging market nations, excluding China. 2024 YTD performance: 12.9% Historical ...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (trade name: Fosun Pharma) is a Chinese pharmaceutical company.It is mostly owned by Fosun International. [2]As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. [3]
In March 2005 the firm acquired Agis Industries Limited (traded as AGIS at the Tel Aviv Stock Exchange), an Israel-based generic pharmaceuticals company in an $850 million transaction. Agis was founded in 1983 by Mori Arkin, who developed his father's small drug import business into a multinational generic pharmaceutical company. As a result of ...
The iShares Trust-China Large-Cap ETF also sport multiple lines of at-money and upside calls with sizeable open interest, including almost 100,000 contracts at the 29.85 strike. The ETF was ...
Broadly speaking, emerging markets a mess this year and the coronavirus is just one reason. What's interesting about that scenario is that China - previously the epicenter of the virus - is ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The iShares China Large-Cap ETF (FXI) , the biggest China-specific ETF by assets under management, is higher by almost 4.4% this month and that puts the benchmark China fund in position for a ...